Arundel, United Kingdom

Ernest Lionel Gilbert Rivett

This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernest Lionel Gilbert Rivett. Retrieved from https://idiyas.com/inventor/ernest-lionel-gilbert-rivett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernest Lionel Gilbert Rivett

Introduction

Ernest Lionel Gilbert Rivett is a notable inventor based in Arundel, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of delayed release formulations. His work has implications for improving the efficacy of antibiotic treatments.

Latest Patents

Rivett holds a patent for a delayed release pharmaceutical formulation containing a β-lactam antibiotic. This innovative formulation includes a matrix that comprises a β-lactam antibiotic, a β-lactamase inhibitor, and granules in a delayed release form. This combination aims to enhance the effectiveness of oral administration of antibiotics.

Career Highlights

Rivett has been associated with SmithKline Beecham Corporation, where he has contributed to various pharmaceutical advancements. His expertise in drug formulation has positioned him as a key figure in the industry.

Collaborations

Throughout his career, Rivett has worked alongside notable colleagues such as Francis Walter Grimmett and Michael William Hartnell. Their collaborative efforts have furthered research and development in pharmaceutical sciences.

Conclusion

Ernest Lionel Gilbert Rivett's contributions to pharmaceutical formulations demonstrate his innovative spirit and dedication to improving healthcare. His work continues to influence the field of medicine and antibiotic treatment strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…